REFRACTORY MIXED PHENOTYPE ACUTE LEUKEMIA
Clinical trials for REFRACTORY MIXED PHENOTYPE ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY MIXED PHENOTYPE ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY MIXED PHENOTYPE ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets Hard-to-Cure leukemia in early trial
Disease control OngoingThis early-stage study tests whether adding immune-boosting drugs (nivolumab and ipilimumab) to blinatumomab can help people with a severe form of B-cell leukemia that has returned or not responded to treatment. The main goals are to find safe doses and understand side effects. A…
Matched conditions: REFRACTORY MIXED PHENOTYPE ACUTE LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:13 UTC
-
New hope for kids with relapsed leukemia: drug combo targets hidden cancer cells
Disease control OngoingThis early-phase trial tests a new drug called uproleselan combined with standard chemotherapy (fludarabine and cytarabine) in children and teens with acute myeloid leukemia, myelodysplastic syndrome, or mixed phenotype acute leukemia that has returned or not responded to treatme…
Matched conditions: REFRACTORY MIXED PHENOTYPE ACUTE LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Promising new combo targets tough infant leukemia
Disease control OngoingThis study tests a new oral drug (revumenib) combined with chemotherapy in infants and young children up to 6 years old whose leukemia has returned or not responded to treatment. The leukemia must have a specific genetic change called KMT2A rearrangement. The goal is to see if th…
Matched conditions: REFRACTORY MIXED PHENOTYPE ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 15, 2026 11:56 UTC